Factors affecting symptom duration and recovery among home-treated COVID- 19 patients in Baghdad-Iraq: a cross-sectional study
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Over 30% of home-treated coronavirus disease-2019 patients experienced Long COVID symptoms lasting more than four weeks. Factors like age, comorbidities, and smoking influenced symptom duration in these Long COVID cases.
Area Of Science
- Infectious Diseases
- Public Health
- Epidemiology
Background
- Coronavirus disease-2019 (COVID-19) can lead to persistent symptoms, a condition known as Long COVID.
- Understanding the prevalence and influencing factors of Long COVID in home-treated populations is crucial for public health management.
Purpose Of The Study
- To determine the prevalence of Long COVID among individuals treated for COVID-19 at home.
- To identify factors associated with the duration of persistent symptoms post-COVID-19.
Main Methods
- A cross-sectional study was conducted with 400 participants diagnosed with COVID-19 via PCR and treated at home.
- Data collected included demographics, comorbidities, smoking history, and symptom duration using questionnaires and physical measurements.
- Statistical analysis was performed using SPSS 27.
Main Results
- 30.25% of participants experienced symptoms lasting longer than four weeks, indicative of Long COVID.
- Fatigue was the most common persistent symptom (23.5%), followed by loss of smell/taste (14.75%).
- Age, smoking status, comorbidities, and the initial number of symptoms significantly correlated with longer illness duration (p<0.05).
Conclusions
- A significant proportion of mild to moderate COVID-19 cases develop persistent symptoms (Long COVID).
- Factors such as older age, presence of comorbidities, and smoking status are associated with prolonged symptom duration.
- The initial symptom burden in COVID-19 may also predict the duration of post-acute sequelae.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Stages of infection describe what happens to a susceptible host once a pathogen invades the human body. The stages of infection are incubation, prodromal, illness, stage of decline, and convalescence. The incubation stage is the period from exposure to a pathogen until symptoms start. The infected person is unaware of impending illness as the pathogens grow and multiply within the body. The duration may vary depending on the type of infection. The incubation period of measles averages ten to...
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
The pathophysiology of pneumonia involves the following steps:
• Inhalation of Infectious Agents: Pneumonia typically begins when pathogenic organisms (bacteria, viruses, fungi) are inhaled or aspirated into the lower respiratory tract.
• Overcoming Lung Defenses: Ideally, the respiratory tract has defense mechanisms like mucociliary clearance and cough reflex to prevent the establishment of pathogenic organisms. If these defenses are compromised, or the pathogen is highly...
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
• For...